This Department of Defense grant supports the Combat Casualty Care Research Program, focusing on applied research and advanced technology development. The grant is for refining concepts into potential solutions for military health and performance problems, evaluating technical feasibility, and developing candidate solutions for early prototype systems. It will fund promising drug, vaccine, medical device, and technology candidates for initial safety and efficacy testing in small-scale human clinical trials (Phase I or early Phase II). Successful proposals must demonstrate strong scientific rationale, well-formulated hypotheses, and provide preliminary data. This grant specifically excludes fundamental basic research, late-phase clinical trials, or advanced product development, aiming to advance early-stage military medical solutions.
Opportunity ID: 217613
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-13-CCCJPC6-FSERC |
| Funding Opportunity Title: | DoD Forward Surgical and En Route Care |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 8 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 9 |
| Posted Date: | Jan 24, 2013 |
| Last Updated Date: | Apr 12, 2013 |
| Original Closing Date for Applications: | May 06, 2013 |
| Current Closing Date for Applications: | May 06, 2013 |
| Archive Date: | Jun 05, 2013 |
| Estimated Total Program Funding: | $17,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | This Program Announcement/Funding Opportunity is focused on specific research topics ofThe Combat Casualty Care Research Program as outlined in Section B. Investigators must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the proposal to be competitive. Research projects should include a well-formulated, testable hypothesis based on a strong scientific rationale. This award mechanism is focused on applied research, defined as research that refines concepts and ideas into potential solutions to military health and performance problems with a view toward evaluating technical feasibility; includes studies and investigations leading to candidate solutions in preparation for initial human testing. This award mechanism will also support advanced technology development which is defined as research for the development of candidate solutions and components of early prototype systems for test and evaluation. Promising drug and vaccine candidates and medical devices and technologies are selected for initial safety and efficacy testing in small scale human clinical trials. Applications may include phase I or early phase II clinical trials, but not late phase II large-scale effectiveness clinical trials or advanced development of products and capabilities. Preliminary data are required for applied research and advanced technology development applications. Awards may not be used to support fundamental basic research, defined as research directed toward attaining a greater knowledge and understanding of fundamental principles of science and medicine relevant to the improvement of medical care in operationally relevant environments.A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g.device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratoryinformation, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
programannouncements@tatrc.org
Email:programannouncements@tatrc.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Please see Full Announcement Tab of the Program Announcement for the revised Attachment 1 – Biosketch Form revised 4-12-13. | Apr 12, 2013 | |
| Please see Full Announcement Tab of the Program Announcement for the revised Attachment 1 – Biosketch Form revised 4-12-13. | Apr 12, 2013 | |
| Revised Attachment – Biographical Sketch Form (4 pages). See the Full Announcement Tab of this Program Announcement for the revised form. | Apr 12, 2013 | |
| Revised Attachment – Biographical Sketch Form (4 pages). See the Full Announcement Tab of this Program Announcement for the revised form. | Apr 11, 2013 | |
| Please see the Full Announcement Tab to access attached forms specified in the Program Announcement. | Apr 11, 2013 | |
| Please see the Full Announcement Tab to access attached forms specified in the Program Announcement. | Apr 10, 2013 | |
| see Attachments under Other Supporting Documents for the revised Quad Chart to this Program Annnouncement | Apr 10, 2013 | |
| See Revised Program Announcement for changes to the following: 1) Page 11, Paragragh II. Submission Information. Replaced the Pre-application submission website from: https://tatrc.aibs.org to: https://tatrc-FSERC.aibs.org; 2) Moved page 11, Paragraph II.B. Pre-Application Submission Content, Form, and Screening sentence, |
Feb 13, 2013 | |
| Jan 25, 2013 |
DISPLAYING: Synopsis 9
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-13-CCCJPC6-FSERC |
| Funding Opportunity Title: | DoD Forward Surgical and En Route Care |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 8 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 9 |
| Posted Date: | Jan 24, 2013 |
| Last Updated Date: | Apr 12, 2013 |
| Original Closing Date for Applications: | May 06, 2013 |
| Current Closing Date for Applications: | May 06, 2013 |
| Archive Date: | Jun 05, 2013 |
| Estimated Total Program Funding: | $17,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | This Program Announcement/Funding Opportunity is focused on specific research topics ofThe Combat Casualty Care Research Program as outlined in Section B. Investigators must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the proposal to be competitive. Research projects should include a well-formulated, testable hypothesis based on a strong scientific rationale. This award mechanism is focused on applied research, defined as research that refines concepts and ideas into potential solutions to military health and performance problems with a view toward evaluating technical feasibility; includes studies and investigations leading to candidate solutions in preparation for initial human testing. This award mechanism will also support advanced technology development which is defined as research for the development of candidate solutions and components of early prototype systems for test and evaluation. Promising drug and vaccine candidates and medical devices and technologies are selected for initial safety and efficacy testing in small scale human clinical trials. Applications may include phase I or early phase II clinical trials, but not late phase II large-scale effectiveness clinical trials or advanced development of products and capabilities. Preliminary data are required for applied research and advanced technology development applications. Awards may not be used to support fundamental basic research, defined as research directed toward attaining a greater knowledge and understanding of fundamental principles of science and medicine relevant to the improvement of medical care in operationally relevant environments.A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g.device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratoryinformation, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
programannouncements@tatrc.org
Email:programannouncements@tatrc.org |
DISPLAYING: Synopsis 8
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-13-CCCJPC6-FSERC |
| Funding Opportunity Title: | DoD Forward Surgical and En Route Care |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 8 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 8 |
| Posted Date: | Apr 12, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 06, 2013 |
| Archive Date: | Jun 05, 2013 |
| Estimated Total Program Funding: | $17,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | This Program Announcement/Funding Opportunity is focused on specific research topics ofThe Combat Casualty Care Research Program as outlined in Section B. Investigators must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the proposal to be competitive. Research projects should include a well-formulated, testable hypothesis based on a strong scientific rationale. This award mechanism is focused on applied research, defined as research that refines concepts and ideas into potential solutions to military health and performance problems with a view toward evaluating technical feasibility; includes studies and investigations leading to candidate solutions in preparation for initial human testing. This award mechanism will also support advanced technology development which is defined as research for the development of candidate solutions and components of early prototype systems for test and evaluation. Promising drug and vaccine candidates and medical devices and technologies are selected for initial safety and efficacy testing in small scale human clinical trials. Applications may include phase I or early phase II clinical trials, but not late phase II large-scale effectiveness clinical trials or advanced development of products and capabilities. Preliminary data are required for applied research and advanced technology development applications. Awards may not be used to support fundamental basic research, defined as research directed toward attaining a greater knowledge and understanding of fundamental principles of science and medicine relevant to the improvement of medical care in operationally relevant environments.A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g.device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratoryinformation, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
programannouncements@tatrc.org
Email:programannouncements@tatrc.org |
DISPLAYING: Synopsis 7
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-13-CCCJPC6-FSERC |
| Funding Opportunity Title: | DoD Forward Surgical and En Route Care |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 8 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 7 |
| Posted Date: | Apr 12, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 06, 2013 |
| Archive Date: | Jun 05, 2013 |
| Estimated Total Program Funding: | $17,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | This Program Announcement/Funding Opportunity is focused on specific research topics ofThe Combat Casualty Care Research Program as outlined in Section B. Investigators must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the proposal to be competitive. Research projects should include a well-formulated, testable hypothesis based on a strong scientific rationale. This award mechanism is focused on applied research, defined as research that refines concepts and ideas into potential solutions to military health and performance problems with a view toward evaluating technical feasibility; includes studies and investigations leading to candidate solutions in preparation for initial human testing. This award mechanism will also support advanced technology development which is defined as research for the development of candidate solutions and components of early prototype systems for test and evaluation. Promising drug and vaccine candidates and medical devices and technologies are selected for initial safety and efficacy testing in small scale human clinical trials. Applications may include phase I or early phase II clinical trials, but not late phase II large-scale effectiveness clinical trials or advanced development of products and capabilities. Preliminary data are required for applied research and advanced technology development applications. Awards may not be used to support fundamental basic research, defined as research directed toward attaining a greater knowledge and understanding of fundamental principles of science and medicine relevant to the improvement of medical care in operationally relevant environments.A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g.device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratoryinformation, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
programannouncements@tatrc.org
Email:programannouncements@tatrc.org |
DISPLAYING: Synopsis 6
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-13-CCCJPC6-FSERC |
| Funding Opportunity Title: | DoD Forward Surgical and En Route Care |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 8 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 6 |
| Posted Date: | Apr 11, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 06, 2013 |
| Archive Date: | Jun 05, 2013 |
| Estimated Total Program Funding: | $17,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | This Program Announcement/Funding Opportunity is focused on specific research topics ofThe Combat Casualty Care Research Program as outlined in Section B. Investigators must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the proposal to be competitive. Research projects should include a well-formulated, testable hypothesis based on a strong scientific rationale. This award mechanism is focused on applied research, defined as research that refines concepts and ideas into potential solutions to military health and performance problems with a view toward evaluating technical feasibility; includes studies and investigations leading to candidate solutions in preparation for initial human testing. This award mechanism will also support advanced technology development which is defined as research for the development of candidate solutions and components of early prototype systems for test and evaluation. Promising drug and vaccine candidates and medical devices and technologies are selected for initial safety and efficacy testing in small scale human clinical trials. Applications may include phase I or early phase II clinical trials, but not late phase II large-scale effectiveness clinical trials or advanced development of products and capabilities. Preliminary data are required for applied research and advanced technology development applications. Awards may not be used to support fundamental basic research, defined as research directed toward attaining a greater knowledge and understanding of fundamental principles of science and medicine relevant to the improvement of medical care in operationally relevant environments.A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g.device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratoryinformation, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
programannouncements@tatrc.org
Email:programannouncements@tatrc.org |
DISPLAYING: Synopsis 5
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-13-CCCJPC6-FSERC |
| Funding Opportunity Title: | DoD Forward Surgical and En Route Care |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 8 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 5 |
| Posted Date: | Apr 11, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 06, 2013 |
| Archive Date: | Jun 05, 2013 |
| Estimated Total Program Funding: | $17,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | This Program Announcement/Funding Opportunity is focused on specific research topics ofThe Combat Casualty Care Research Program as outlined in Section B. Investigators must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the proposal to be competitive. Research projects should include a well-formulated, testable hypothesis based on a strong scientific rationale. This award mechanism is focused on applied research, defined as research that refines concepts and ideas into potential solutions to military health and performance problems with a view toward evaluating technical feasibility; includes studies and investigations leading to candidate solutions in preparation for initial human testing. This award mechanism will also support advanced technology development which is defined as research for the development of candidate solutions and components of early prototype systems for test and evaluation. Promising drug and vaccine candidates and medical devices and technologies are selected for initial safety and efficacy testing in small scale human clinical trials. Applications may include phase I or early phase II clinical trials, but not late phase II large-scale effectiveness clinical trials or advanced development of products and capabilities. Preliminary data are required for applied research and advanced technology development applications. Awards may not be used to support fundamental basic research, defined as research directed toward attaining a greater knowledge and understanding of fundamental principles of science and medicine relevant to the improvement of medical care in operationally relevant environments.A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g.device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratoryinformation, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
programannouncements@tatrc.org
Email:programannouncements@tatrc.org |
DISPLAYING: Synopsis 4
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-13-CCCJPC6-FSERC |
| Funding Opportunity Title: | DoD Forward Surgical and En Route Care |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 8 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | Apr 10, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 06, 2013 |
| Archive Date: | Jun 05, 2013 |
| Estimated Total Program Funding: | $17,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | This Program Announcement/Funding Opportunity is focused on specific research topics ofThe Combat Casualty Care Research Program as outlined in Section B. Investigators must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the proposal to be competitive. Research projects should include a well-formulated, testable hypothesis based on a strong scientific rationale. This award mechanism is focused on applied research, defined as research that refines concepts and ideas into potential solutions to military health and performance problems with a view toward evaluating technical feasibility; includes studies and investigations leading to candidate solutions in preparation for initial human testing. This award mechanism will also support advanced technology development which is defined as research for the development of candidate solutions and components of early prototype systems for test and evaluation. Promising drug and vaccine candidates and medical devices and technologies are selected for initial safety and efficacy testing in small scale human clinical trials. Applications may include phase I or early phase II clinical trials, but not late phase II large-scale effectiveness clinical trials or advanced development of products and capabilities. Preliminary data are required for applied research and advanced technology development applications. Awards may not be used to support fundamental basic research, defined as research directed toward attaining a greater knowledge and understanding of fundamental principles of science and medicine relevant to the improvement of medical care in operationally relevant environments.A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g.device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratoryinformation, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
programannouncements@tatrc.org
Email:programannouncements@tatrc.org |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-13-CCCJPC6-FSERC |
| Funding Opportunity Title: | DoD Forward Surgical and En Route Care |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 8 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Apr 10, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 06, 2013 |
| Archive Date: | Jun 05, 2013 |
| Estimated Total Program Funding: | $17,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | This Program Announcement/Funding Opportunity is focused on specific research topics ofThe Combat Casualty Care Research Program as outlined in Section B. Investigators must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the proposal to be competitive. Research projects should include a well-formulated, testable hypothesis based on a strong scientific rationale. This award mechanism is focused on applied research, defined as research that refines concepts and ideas into potential solutions to military health and performance problems with a view toward evaluating technical feasibility; includes studies and investigations leading to candidate solutions in preparation for initial human testing. This award mechanism will also support advanced technology development which is defined as research for the development of candidate solutions and components of early prototype systems for test and evaluation. Promising drug and vaccine candidates and medical devices and technologies are selected for initial safety and efficacy testing in small scale human clinical trials. Applications may include phase I or early phase II clinical trials, but not late phase II large-scale effectiveness clinical trials or advanced development of products and capabilities. Preliminary data are required for applied research and advanced technology development applications. Awards may not be used to support fundamental basic research, defined as research directed toward attaining a greater knowledge and understanding of fundamental principles of science and medicine relevant to the improvement of medical care in operationally relevant environments.A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g.device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratoryinformation, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
programannouncements@tatrc.org
Email:programannouncements@tatrc.org |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-13-CCCJPC6-FSERC |
| Funding Opportunity Title: | DoD Forward Surgical and En Route Care |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 8 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Feb 13, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 06, 2013 |
| Archive Date: | Jun 05, 2013 |
| Estimated Total Program Funding: | $17,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | This Program Announcement/Funding Opportunity is focused on specific research topics ofThe Combat Casualty Care Research Program as outlined in Section B. Investigators must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the proposal to be competitive. Research projects should include a well-formulated, testable hypothesis based on a strong scientific rationale. This award mechanism is focused on applied research, defined as research that refines concepts and ideas into potential solutions to military health and performance problems with a view toward evaluating technical feasibility; includes studies and investigations leading to candidate solutions in preparation for initial human testing. This award mechanism will also support advanced technology development which is defined as research for the development of candidate solutions and components of early prototype systems for test and evaluation. Promising drug and vaccine candidates and medical devices and technologies are selected for initial safety and efficacy testing in small scale human clinical trials. Applications may include phase I or early phase II clinical trials, but not late phase II large-scale effectiveness clinical trials or advanced development of products and capabilities. Preliminary data are required for applied research and advanced technology development applications. Awards may not be used to support fundamental basic research, defined as research directed toward attaining a greater knowledge and understanding of fundamental principles of science and medicine relevant to the improvement of medical care in operationally relevant environments.A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g.device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratoryinformation, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
programannouncements@tatrc.org
Email:programannouncements@tatrc.org |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-13-CCCJPC6-FSERC |
| Funding Opportunity Title: | DoD Forward Surgical and En Route Care |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 8 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 25, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 06, 2013 |
| Archive Date: | Jun 05, 2013 |
| Estimated Total Program Funding: | $17,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | This Program Announcement/Funding Opportunity is focused on specific research topics of The Combat Casualty Care Research Program as outlined in Section B. Investigators must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the proposal to be competitive. Research projects should include a well-formulated, testable hypothesis based on a strong scientific rationale. This award mechanism is focused on applied research, defined as research that refines concepts and ideas into potential solutions to military health and performance problems with a view toward evaluating technical feasibility; includes studies and investigations leading to candidate solutions in preparation for initial human testing. This award mechanism will also support advanced technology development which is defined as research for the development of candidate solutions and components of early prototype systems for test and evaluation. Promising drug and vaccine candidates and medical devices and technologies are selected for initial safety and efficacy testing in small scale human clinical trials. Applications may include phase I or early phase II clinical trials, but not late phase II large-scale effectiveness clinical trials or advanced development of products and capabilities. Preliminary data are required for applied research and advanced technology development applications. Awards may not be used to support fundamental basic research, defined as research directed toward attaining a greater knowledge and understanding of fundamental principles of science and medicine relevant to the improvement of medical care in operationally relevant environments. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g.device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratory |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
programannouncements@tatrc.org
Email:programannouncements@tatrc.org |
Related Documents
Folder 217613 Full Announcement-1 -> w81xwh-13-cccjpc6-fserc program announcement.pdf
Folder 217613 Revised Full Announcement-1 -> w81xwh-13-cccjpc6-fserc revised progann 1-25-13.pdf
Folder 217613 Other Supporting Documents-Attachment 1- Biographical Sketch 1 -> attachment 1 – biographical sketch.pdf
Folder 217613 Other Supporting Documents-Attachment 2 – Abstract 1 -> attachment 2 – abstract.pdf
Folder 217613 Other Supporting Documents-Attachment 5 – Representations for Assistance Agreements 1 -> attachment 5 – representations for assistance agreements.pdf
Folder 217613 Other Supporting Documents-Attachment 6 – Certifications and Assurances for Assistance Agreements 1 -> attachment 6 – certifications and assurances for assistance agreements.pdf
Folder 217613 Other Supporting Documents-Quad chart 1 -> fsercquadcharttemplate.pdf
Folder 217613 Other Supporting Documents-Revised 4-12-13 Attachment 1 – Biosketch Form 1 -> attachment 1 – biosketch form revised 4-12-13.pdf
Folder 217613 Other Supporting Documents-revised attachment – Biographical Sketch (4 pages) 1 -> biosketchform- 4 pgs.pdf
Packages
| Agency Contact Information: | programannouncements@tatrc.org Email: programannouncements@tatrc.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00161950 | Jan 24, 2013 | May 06, 2013 | View |
Package 1
Mandatory forms
217613 RR_SF424_1_2-1.2.pdf
217613 RR_KeyPersonExpanded_1_2-1.2.pdf
217613 PerformanceSite_1_4-1.4.pdf
217613 RR_Budget-1.1.pdf
217613 RR_OtherProjectInfo_1_3-1.3.pdf
Optional forms
217613 RR_SubawardBudget-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
